Last Update

2016-05-24T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Nabil Dib?

Dr. Nabil Dib

Direct Phone: (602) ***-**** ext. ****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Founder and President

International Society for Cardiovascular Translational Research

Director Cardiovascular Research

Dignity Health

Affiliations

Scientific Advisory Board Member
Ventrix Inc

SCIENTIFIC ADVISORY BOARD Member
Cardiology Online Inc

Medical Advisor
Cardiovascular Systems Inc

Special Advisor To Board of Directors
Stemedica Cell Technologies Inc

Founder
Cardiovascular and Stem Cell Consultants

Education

Arizona Heart Institute

Tufts University School of Medicine

Degree in Master of Science

Epidemiology

Harvard Medical School

M.D.

M.D.

University of California , San Diego

MSc

Medical Degree

Damascus University School of Medicine

Myocardial Stem Cell

degree in Master of Science

Epidemiology and Research

Harvard School of Public Health

master's degree

epidemiology

Harvard School of Public Health

medical degree

Damascus University

Web References (198 Total References)


Breaking News for 2002

www.grg.org [cached]

Dr. Francis Pagani of the University of Michigan, Dr. Philippe Menasche of the Georges Pompidou European Hospital in Paris, and Dr. Nabil Dib of the Arizona Heart Institute in Phoenix are all performing some of these trials on small numbers of patients, all of which leads to anecdotal reports of great promise.


Investor Relations | Osiris Launches the First Trial Using Adult Universal Stem Cells in Cardiac Patients.

osir.client.shareholder.com [cached]

“We are investigating an exciting new approach to address the unmet needs of cardiac patients,†said Dr. Nabil Dib, Chief of Cardiovascular Research at the Arizona Heart Institute, another investigator in the trial. “According to the American Heart Association, about two thirds of heart attack patients never completely recover.


3rd World Congress on Heart Disease - Preliminary Presentations

www.cardiologyonline.com [cached]

Nabil Dib , Arizona Heart Institute and Hospital, Phoenix, AZ, U.S.A.


It's ludicrous to say we must ...

healthcommentary.org [cached]

It's ludicrous to say we must understand the molecular mechanisms before we can try anything."(4) Dr. Nabil Dib of the Arizona Heart Institute voiced a common hope for stem cell use in heart disease when he said, "If this proves efficacious, this will replace heart transplants. (2)


It's ludicrous to say we must ...

healthcommentary.org [cached]

It's ludicrous to say we must understand the molecular mechanisms before we can try anything."(4) Dr. Nabil Dib of the Arizona Heart Institute voiced a common hope for stem cell use in heart disease when he said, "If this proves efficacious, this will replace heart transplants. (2)

Similar Profiles

Other People with this Name

Other people with the name Dib

Chuck Dib
3D Advisors Inc

Matt Dib
3D Advisors Inc

Elie Dib
IHA Inc

Ray Dib

Gaby Dib
RYMCO

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory